EyePoint Pharmaceuticals, Inc. announced the appointment of David Guyer, M.D., to the Company's Board of Directors. He will also serve on the Company's Science Committee. Dr. Guyer has led several public and private biotechnology companies focused on ocular diseases, and has held leadership positions in academia and at healthcare venture capital firms. Dr. Guyer currently serves as Executive Chairman of Ophthotech Corporation.